Intermediate Studies for Modified Release Formulations
Intermediate Studies for Modified Release Formulations Designing Intermediate Stability Studies for Modified Release Formulations: A Regulatory and Analytical Guide Modified release (MR) formulations—including extended-release, delayed-release, and controlled-release dosage forms—are among the most complex drug delivery systems in the pharmaceutical market. Ensuring their stability over time is essential, and intermediate studies at 30°C ± 2°C /…
Read More “Intermediate Studies for Modified Release Formulations” »